Class II
Drug Recall: Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873. NDC: 70069-0836-01
Reliance Life Sciences Private Limited · June 24, 2026
Reason for Recall
Lack of Sterility Assurance
Distribution
Nationwide in the USA
States Affected
NATIONWIDE
Quantity Affected
11,400 vials
Source: FDA (openFDA Drug Enforcement)
Recall number: D-0673-2026
Status: ongoing
SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.